KTTA Stock Summary and Trading Ideas (Pasithea Therapeutics Corp. | NASDAQ:KTTA)

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

What symbol and exchange does Pasithea Therapeutics Corp. shares trade?

Pasithea Therapeutics Corp. trades on the NASDAQ stock market under the symbol KTTA.

What is Pasithea Therapeutics Corp. stock price doing today?

As of September 4, 2026, KTTA stock price was flat at $0.58 with 222,213 million shares trading.

What is Pasithea Therapeutics Corp.'s Beta?

KTTA has a beta of 5.74, meaning it tends to be more sensitive to market movements. KTTA has a correlation of 0.12 to the broad based SPY ETF.

How much is Pasithea Therapeutics Corp. worth?

KTTA has a market cap of $19.38 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Pasithea Therapeutics Corp. traded in the last 3 year period?

In the last 3 years, KTTA traded as high as $17.40 and as low as $.28.

What are the top ETFs holding Pasithea Therapeutics Corp.?

The top ETF exchange traded funds that KTTA belongs to (by Net Assets): PSIL, VXF.

Is Pasithea Therapeutics Corp. (KTTA) a good investment?

KTTA has underperformed the market in the last year with a return of -27.1%, while the SPY ETF gained +19.8%. In the last 3 month period, KTTA fell short of the market, returning -6.4%, while SPY returned +2.0%. However, in the most recent 2 weeks KTTA has outperformed the stock market by returning +7.5%, while SPY returned +0.6%.

What are the support and resistance levels for Pasithea Therapeutics Corp. (KTTA)?

KTTA support price is $.54 and resistance is $.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KTTA shares will trade within this expected range on the day.